Sonova, the Swiss parent company of Phonak and Unitron , reported on November 12 that it has raised its full-year outlook after double-digit wholesale hearing aid growth lifted first-half sales and operating profit above analyst expectations. Revenue from continuing operations reached CHF 1.83 billion (US$2.20 billion) for the 6 months ended September 30, 2026, up 7.5% at constant exchange rates....
Continue reading at Hearing Tracker
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable clinical change — this is a corporate financial update with no direct implications for hearing care practice.
An 11% wholesale hearing aid sales surge and upgraded outlook from Sonova signals continued strong market demand, which may influence product availability, pricing, and competitive dynamics for independent clinics.
- 01Sonova raised its full-year financial outlook on November 12 following strong first-half results.
- 02Hearing aid sales at the wholesale level grew 11% in the first half.
- 03Both revenue and operating profit exceeded analyst expectations.
- 04Growth was driven by the wholesale (manufacturer) segment specifically.
- 05Sonova's brands include Phonak, Unitron, Hansaton, and Advanced Bionics.
Sonova's wholesale hearing aid sales grew 11% in the first half of the fiscal year.
press releasesupportedFirst-half revenue and operating profit exceeded analyst expectations.
press releasesupported